Sr. Executive - Information Technology

Job Description:

Intas Pharmaceuticals is seeking a Sr. Executive – Information Technology to join their dynamic team and drive innovation through AI and machine learning solutions. The focuses on developing intelligent applications, leveraging modern AI frameworks, and integrating advanced technologies to support business transformation.

Roles & Responsibilities:

• Design and implement AI/ML-based solutions using Python and modern open-source frameworks
• Develop and deploy applications powered by large language models using tools like LangChain, Ollama, and Azure-based AI platforms
• Integrate AI solutions with APIs, databases, and enterprise applications for seamless functionality
• Work on advanced techniques such as retrieval-augmented generation (RAG), prompt engineering, and model optimization
• Evaluate and select appropriate AI models (open-source or cloud-based) based on business requirements
• Collaborate with cross-functional teams to convert business challenges into scalable AI-driven solutions
• Maintain and optimize AI applications for performance, scalability, and reliability
• Stay updated with emerging trends in Generative AI, LLMs, and related technologies
• Ensure proper version control, deployment practices, and documentation using tools like Git and Docker
• Support cloud-based deployments and integrations across platforms such as Azure, AWS, or GCP

Intas Pharmaceuticals Ltd. is a leading vertically integrated global pharmaceutical company engaged in formulation development, manufacturing, and marketing. The company is committed to addressing unmet medical and societal needs through a strong and comprehensive pharmaceutical value chain.

It operates globally through its subsidiaries under the brand
Accord Healthcare, enabling a strong presence in international markets.

Global Presence & Growth

• Present in 85+ countries worldwide
• Strong presence in North America, Europe, Latin America, Asia-Pacific, CIS & MENA regions
• Over 70% revenue from global markets
• Achieved ~19% CAGR growth
• Crossed $2.5 billion revenue milestone
• Ranked 6th in the Indian pharmaceutical market
• Among the top 10 generic players in regulated markets like the EU, US & UK

Infrastructure & Workforce

• 17 advanced facilities (manufacturing, R&D, distribution)
  • 10 in India
  • Others in the UK, Mexico & Greece
• Facilities approved by global regulators such as:
  • USFDA, EMA, MHRA, TGA, etc.
• Strong workforce of 23,000+ employees

Research & Development (R&D)

• Invests 6–7% of revenue in R&D
• 10,000+ product registrations worldwide
• Pipeline of 300+ high-value products including:
  • Biosimilars
  • New Drug Delivery Systems (NDDS)
  • First-to-File / First-to-Market products

Key Therapeutic Areas

• CNS (Central Nervous System)
• Cardiology
• Diabetology
• Gastroenterology
• Urology
• Oncology
• Animal Health

Specialized Capabilities

• Advanced Biopharma division focused on “Biosimilars for Billions”
• Expertise in niche therapies:
  • Oncology
  • Auto-immune diseases
  • Ophthalmology
  • Nephrology
  • Rheumatology
  • Hormone therapies
• Plasma Fractionation Unit for plasma-derived therapeutics with WHO-GMP certification

Quality & Compliance

• Manufacturing facilities approved by major global regulatory agencies
• Adherence to highest international quality standards
• Strong in-house development and quality control systems

Core Values

• Innovation – Driving continuous improvement
• Quality – Maintaining global standards
• Added Value – Delivering beyond expectations
• Growth – Continuous progress and expansion
• Commitment – Dedication to excellence
• Customer Delight & Collaboration
• Performance Focus & Care for Society

People & Culture

• Focus on attracting and retaining top talent
• Emphasis on diversity and global workforce
• Commitment to empowering employees and fostering growth